cause – Page 20 – Communicable Diseases Research

IgG N-glycome changes during the course of severe COVID-19: An observational study

중증 코로나19 기간 동안 IgG N-글리코메 변화: 관찰 연구

Meta-Analysis

Published on 2022-07-012022-09-12
Journal: EBioMedicine [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단,

[키워드] 95% CI acute respiratory syndrome adjusted Affect age analysed Analysis bind Bisecting GlcNAc cause change changes in circulating Cohort cohorts competence complement system activation contrary coronavirus disease Coronavirus-2 Course COVID-19 COVID-19 case cytotoxicity determine education European Fc region foundation functions Fund Galactosylation glycan glycans glycosylation Health IgG IgG glycosylation immune cells immune response Immunoglobulin immunoglobulins immunosuppressive independent indicate Investment IQR lack magnitude males median age Meta-analysis Mild mild case Molecular epidemiology molecular mechanism Multiple Patient performed problem proinflammatory receptor regulate released Respiratory illness SARS-CoV-2 Science Severe case severe COVID-19 severe COVID-19 patient severity significantly statistically statistically significant supported the disease Youth
[DOI] 10.1016/j.ebiom.2022.104101 PMC 바로가기 [Article Type] Meta-Analysis

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

예방 접종 없이 SARS-CoV-2 Omicron에 대한 제한된 교차 변이 면역

Article

Published on 2022-07-012022-09-11
Journal: Nature [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] Activation arise Brain brains Breakthrough infection cause Cytokines Delta disease elicited ENhance expression human ACE2 receptor humans humoral immune response Immunity individual individuals induce Infection infections lead Limited lung Lung disease Lungs mice Mild Mild disease neutralization neutralize omicron other variant overexpressing pandemic pre-existing immunity pro-inflammatory cytokine pro-inflammatory cytokines question reduced replicate risk SARS-CoV-2 SARS-CoV-2 delta sera Symptoms T cells titre vaccinated individual vaccinated individuals vaccination Vaccine variant variants of concern WA1 widespread
[DOI] 10.1038/s41586-022-04865-0 PMC 바로가기 [Article Type] Article

Case Report of COVID-19 Infection After Kidney Transplant Treated With Casirivimab-Imdevimab and Mycophenolate Mofetil Changed to Everolimus

Article

Published on 2022-07-012022-11-15
Journal: Transplantation proceedings [Category] COVID19(2023년), SARS, 진단,

Drug repurposing to overcome microbial resistance

Review article

Published on 2022-07-012022-10-05
Journal: Drug discovery today [Category] 신약개발,

[키워드] anti-infective drugs Antibiotics antimicrobial resistance approach cause Critical cross-resistant drug Drug repurposing drugs in vitro indication infections microbial multidrug-resistant Non-antibiotic drugs overcome pathogen provided strain Support tested
[DOI] 10.1016/j.drudis.2022.05.006 [Article Type] Review article

SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature

Article

Published on 2022-07-012022-11-16
Journal: Revista Argentina de microbiología [Category] COVID19(2023년), SARS, 치료기술,

[키워드] Antibiotics antimicrobial article association bacterial co-infection bilateral pneumonia cause chest CT scan Chlamydia Chlamydia pneumoniae Co-infection Coinfección Comorbidity consolidation coronavirus Coronavirus 2019 coronavirus disease cough COVID-19 COVID-19 pandemic cross-sectional study database described Dyspnea English English language Evidence Fever Google Google Scholar ground glass ICU admission in viral Infección por SARS-CoV-2 infected with SARS-CoV-2 Infection Intervention laboratory-confirmed majority male media median age Mortality MOST Most patient Pandemia para Patient patients paucity of data pneumoniae Prevalence Prospective ranged reported required respiratory infection respiratory infections retrospective SARS-CoV-2 SARS-COV-2 infection Spanish Support systematic review the patient was performed
[DOI] 10.1016/j.ram.2022.05.009 PMC 바로가기

Detection of COVID-19 from CT and Chest X-ray Images Using Deep Learning Models

딥 러닝 모델을 사용하여 CT 및 흉부 X선 이미지에서 COVID-19 감지

Review

Published on 2022-07-012022-09-11
Journal: Annals of biomedical engineering [Category] COVID19(2023년), SARS, 치료기술,

Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing

Review article

Published on 2022-07-012022-10-05
Journal: Drug discovery today [Category] 신약개발,

Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release

Research

Published on 2022-06-302022-10-05
Journal: Scientific Reports [Category] 진단,

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening

가상 스크리닝을 통한 SARS-CoV-2 주요 프로테아제에 대한 용도 변경 치료제 식별

Article

Published on 2022-06-302022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 신약개발, 치료제,

[키워드] 3CLpro addition applied binding binding energy carried cause Combination common drug coronavirus disease Coronavirus disease 2019 criteria Critical crystal structure drug effective effective drug effective drugs Efficiency enzyme FDA-approved drug FDA-approved drugs feature FIVE global pandemic HBD IC50 identification in viral inhibit inhibit SARS-CoV-2 inhibitor inhibitors Lapatinib molecular molecular docking molecular dynamics molecular dynamics simulations pandemic performed protease provide residue SAR-CoV-2 SARS-CoV-2 SARS-CoV-2 main protease selected these compounds viral replication Virtual screening
[DOI] 10.1371/journal.pone.0269563 PMC 바로가기 [Article Type] Article

Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients

비인두 미생물총의 슈퍼 우세한 병원성 박테리아는 COVID-19 환자에서 2차 박테리아 감염을 유발합니다

Article

Published on 2022-06-292022-09-11
Journal: Microbiology Spectrum [Category] Coronavirus, COVID19(2023년), SARS, 치료기술,

[키워드] 16S rRNA 16S rRNA gene abundance accounted Acinetobacter aggravate analyzed Bacterial Bacterial infection bacterial pneumonia bacterial specy cause collected Community composed coronavirus disease Coronavirus disease 2019 Corynebacterium Coverage COVID-19 COVID-19 infection COVID-19 patient defined difference disease severity Diversity dominant fatality genus High-throughput sequencing Infection Influenza invasive Lower respiratory tract lower respiratory tract samples microbiota Mild mild COVID-19 patients mild infection mild infections nasopharyngeal nasopharyngeal microbiota nasopharynx pathobiontic bacteria pathogen Patient patients patients with SARS-CoV-2 Pneumonia previous study respiratory infectious disease respiratory tracts responsible rRNA Sample SARS-COV-2 infection secondary secondary bacterial infection secondary bacterial pneumonia Seven severe COVID-19 Severe COVID-19 Infection severe COVID-19 patients severe group severe pneumonia significantly significantly higher Staphylococcus upper upper and lower respiratory tracts upper respiratory tract variety was used
[DOI] 10.1128/spectrum.01956-21 PMC 바로가기 [Article Type] Article